BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 36305462)

  • 1. PTEN-knockout regulates metabolic rewiring and epigenetic reprogramming in prostate cancer and chemoprevention by triterpenoid ursolic acid.
    Wang L; Wang C; Sarwar MS; Chou P; Wang Y; Su X; Kong AT
    FASEB J; 2022 Nov; 36(11):e22626. PubMed ID: 36305462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triterpenoid ursolic acid regulates the environmental carcinogen benzo[a]pyrene-driven epigenetic and metabolic alterations in SKH-1 hairless mice for skin cancer interception.
    Sarwar MS; Ramirez CN; Kuo HD; Chou P; Wu R; Sargsyan D; Yang Y; Shannar A; Peter RM; Yin R; Wang Y; Su X; Kong AN
    Carcinogenesis; 2024 May; 45(5):288-299. PubMed ID: 38466106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triterpenoid ursolic acid drives metabolic rewiring and epigenetic reprogramming in treatment/prevention of human prostate cancer.
    Li S; Wu R; Wang L; Dina Kuo HC; Sargsyan D; Zheng X; Wang Y; Su X; Kong AN
    Mol Carcinog; 2022 Jan; 61(1):111-121. PubMed ID: 34727410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nfe2l2 Regulates Metabolic Rewiring and Epigenetic Reprogramming in Mediating Cancer Protective Effect by Fucoxanthin.
    Wang L; Wu R; Sargsyan D; Su S; Kuo HC; Li S; Chou P; Sarwar MS; Phadnis A; Wang Y; Su X; Kong AN
    AAPS J; 2022 Jan; 24(1):30. PubMed ID: 35043283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic and transcriptomic profiling of Pten gene-knockout mouse model of prostate cancer.
    Zhang J; Kim S; Li L; Kemp CJ; Jiang C; Lü J
    Prostate; 2020 May; 80(7):588-605. PubMed ID: 32162714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aqueous metabolome of tissue-specific conditional Pten-knockout mouse prostate cancer and TRAMP neuroendocrine carcinoma.
    Kim S; Li L; Zhang J; Jiang C; Lü J
    Prostate; 2022 Jan; 82(1):154-166. PubMed ID: 34662447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Butyrate Drives Metabolic Rewiring and Epigenetic Reprogramming in Human Colon Cancer Cells.
    Wang L; Shannar AAF; Wu R; Chou P; Sarwar MS; Kuo HC; Peter RM; Wang Y; Su X; Kong AN
    Mol Nutr Food Res; 2022 Jun; 66(12):e2200028. PubMed ID: 35429118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triterpenoid corosolic acid modulates global CpG methylation and transcriptome of tumor promotor TPA induced mouse epidermal JB6 P+ cells.
    Hudlikar RR; Sargsyan D; Wu R; Su S; Zheng M; Kong AN
    Chem Biol Interact; 2020 Apr; 321():109025. PubMed ID: 32135139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN deletion drives aberrations of DNA methylome and transcriptome in different stages of prostate cancer.
    Wang C; Feng Y; Zhang C; Cheng D; Wu R; Yang Y; Sargsyan D; Kumar D; Kong AN
    FASEB J; 2020 Jan; 34(1):1304-1318. PubMed ID: 31914691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylome and transcriptome alterations and cancer prevention by triterpenoid ursolic acid in UVB-induced skin tumor in mice.
    Yang Y; Yin R; Wu R; Ramirez CN; Sargsyan D; Li S; Wang L; Cheng D; Wang C; Hudlikar R; Kuo HC; Lu Y; Kong AN
    Mol Carcinog; 2019 Oct; 58(10):1738-1753. PubMed ID: 31237383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The environmental carcinogen benzo[a]pyrene regulates epigenetic reprogramming and metabolic rewiring in a two-stage mouse skin carcinogenesis model.
    Sarwar MS; Ramirez CN; Dina Kuo HC; Chou P; Wu R; Sargsyan D; Yang Y; Shannar A; Mary Peter R; Yin R; Wang Y; Su X; Kong AN
    Carcinogenesis; 2023 Aug; 44(5):436-449. PubMed ID: 37100755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy inhibition enhances ursolic acid-induced apoptosis in PC3 cells.
    Shin SW; Kim SY; Park JW
    Biochim Biophys Acta; 2012 Feb; 1823(2):451-7. PubMed ID: 22178132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic modifications of triterpenoid ursolic acid in activating Nrf2 and blocking cellular transformation of mouse epidermal cells.
    Kim H; Ramirez CN; Su ZY; Kong AN
    J Nutr Biochem; 2016 Jul; 33():54-62. PubMed ID: 27260468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylseleninic Acid Superactivates p53-Senescence Cancer Progression Barrier in Prostate Lesions of Pten-Knockout Mouse.
    Wang L; Guo X; Wang J; Jiang C; Bosland MC; Lü J; Deng Y
    Cancer Prev Res (Phila); 2016 Jan; 9(1):35-42. PubMed ID: 26511486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways.
    Xing C; Ci X; Sun X; Fu X; Zhang Z; Dong EN; Hao ZZ; Dong JT
    Neoplasia; 2014 Nov; 16(11):883-99. PubMed ID: 25425963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NFATc1 promotes prostate tumorigenesis and overcomes PTEN loss-induced senescence.
    Manda KR; Tripathi P; Hsi AC; Ning J; Ruzinova MB; Liapis H; Bailey M; Zhang H; Maher CA; Humphrey PA; Andriole GL; Ding L; You Z; Chen F
    Oncogene; 2016 Jun; 35(25):3282-92. PubMed ID: 26477312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate.
    Liao CP; Lin TP; Li PC; Geary LA; Chen K; Vaikari VP; Wu JB; Lin CH; Gross ME; Shih JC
    Oncogene; 2018 Sep; 37(38):5175-5190. PubMed ID: 29844571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LZTS2 and PTEN collaboratively regulate ß-catenin in prostatic tumorigenesis.
    Yu EJ; Hooker E; Johnson DT; Kwak MK; Zou K; Luong R; He Y; Sun Z
    PLoS One; 2017; 12(3):e0174357. PubMed ID: 28323888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of hepatocyte growth factor/MET signaling initiates oncogenic transformation and enhances tumor aggressiveness in the murine prostate.
    Mi J; Hooker E; Balog S; Zeng H; Johnson DT; He Y; Yu EJ; Wu H; Le V; Lee DH; Aldahl J; Gonzalgo ML; Sun Z
    J Biol Chem; 2018 Dec; 293(52):20123-20136. PubMed ID: 30401749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RUNX2 overexpression and PTEN haploinsufficiency cooperate to promote CXCR7 expression and cellular trafficking, AKT hyperactivation and prostate tumorigenesis.
    Bai Y; Yang Y; Yan Y; Zhong J; Blee AM; Pan Y; Ma T; Karnes RJ; Jimenez R; Xu W; Huang H
    Theranostics; 2019; 9(12):3459-3475. PubMed ID: 31281490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.